Private Placements, Capital Formation,
Restructuring & Recapitalizations



Dilon Technologies ~ Debt Placement
January 2009 & April 2009

Privately-held Dilon Technologies manufactures and markets medical imaging devices. The Dilon 6800 Gamma Camera with Breast-Specific Gamma Imaging (BSGI) is used as a diagnostic complement to mammography in breast cancer diagnosis, as well as in pre-surgical planning for patients diagnosed with breast cancer. The Dilon camera is the best diagnostic tool for breast cancer today, detecting cancers that standard mammograms can not, and offering a much cheaper solution than other advanced imaging devices like Breast MRI. There are over 90 Dilon cameras installed worldwide and more than 70,000 women have been imaged with them.

Taglich Brothers provided Dilon with capital needed to fund operations, deal with a record backlog, and for the development and the anticipated release of a new biopsy device and related disposables.

The information contained herein does not constitute a solicitation of any order to buy or sell any securities. The information provided herein may be displayed and printed for your personal, noncommercial use only. You may not reproduce, retransmit, distribute, disseminate, sell, publish, broadcast or circulate the information to anyone, without the express written consent of Taglich Brothers, Inc.